Solence

Based in France, Solence focuses on providing digital solutions for women managing Polycystic Ovary Syndrome (PCOS), offering comprehensive support through an innovative application that enhances health outcomes. Founded in 2022 and headquartered in Strasbourg, France, Solence develops a digital application specifically designed for women diagnosed with chronic conditions, particularly PCOS. The firm has completed one deal as of July 2025, raising EUR 1. 6 million in a Seed funding round from Bpifrance and Impact Shakers Ventures, among others.

The founder's details remain unspecified, and there are no mentions of company pivots or subsidiaries. Solence primarily offers a digital application designed to assist women in managing the symptoms of Polycystic Ovary Syndrome (PCOS). The app incorporates over 300 theoretical insights and actionable strategies, focusing on lifestyle modifications in areas such as nutrition, exercise, stress management, environmental health, sleep, and emotional well-being. By doing so, it aims to help users understand their symptoms and observe the potential health effects of the proposed lifestyle changes.

The target clientele comprises women diagnosed with chronic conditions, specifically PCOS, who are seeking comprehensive support and solutions for better health outcomes. Currently, the application is marketed in several geographical regions, focusing on European and North American markets, where awareness and prevalence of PCOS have prompted a demand for targeted health solutions. Solence's revenue model is based on subscription services tailored to individual users seeking ongoing support and guidance through the app. Clients typically engage with the platform through direct-to-consumer transactions, allowing them to access the app's features and resources on a recurring basis.

The subscription structure includes various pricing plans that offer differing levels of access to the app's comprehensive content and features, ensuring continuous user engagement and fostering a relationship with the client base, which comprises women actively managing their health conditions. Solence's revenue generation strategy is further supported by partnerships with healthcare professionals and institutions that enhance the credibility and reach of its digital offerings. In July 2025, Solence raised EUR 1. 6 million in Seed funding from new investors Impact Shakers Ventures and Bpifrance, which will be utilized to support its expansion plans and product development.

The company aims to enhance its application with new features and is focused on expanding its market presence in Europe and North America. Specific markets targeted for expansion have not been detailed, but the funding will facilitate these growth initiatives.